nach oben

Psychiatric Quarterly

Erschienen in:

21.06.2017 | Original Paper

Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder

verfasst von: Elina A. Stefanovics, Robert A. Rosenheck, Karen M. Jones, Grant Huang, John H. Krystal

Erschienen in: Psychiatric Quarterly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

This study sought to determine the minimal clinically important difference (MCID) for two frequently used measures of symptom severity in Post-Traumatic Stress Disorder: the Clinician Administered PTSD Scale (CAPS) and the PTSD Symptom Checklist (PCL). Data from a randomized clinical trial of antipsychotic medication in military-related treatment-resistant PTSD (N= 267) included assessments 4 times over 26 weeks. Methods for estimating the MCID were based on both the anchor-based approach, using the Clinical Global Impressions (CGI) severity and improvement scales, rated by both clinicians and patients; and the distribution-based approach (based on standardized z-scores). Severity and change scores on the CAPS and PCL were converted to z-scores and compared across CGI levels using analysis of variance. The average difference in CAPS z-scores between each of three CGI levels between “moderate” to “severe” and from “no change” to “much improved” was 0.758 for clinician CGI ratings and 0.525 for patient CGI ratings and were similar for the PCL (0.483 and 0.471) with all differences significant at p<.0001). Clinically meaningful CAPS and PCL severity and change z-scores range between 0.5–0.8 standard deviations. The MCID estimates suggested here provide an empirical basis for determining whether statistically significant changes in CAPS and PCL scores are clinically meaningful.

Breslau, N., Davis, G. C., Andreski, P., & Peterson, E. (1991). Traumatic events and posttraumatic stress disorder in an urban population of young adults. Archives of general psychiatry, 48(3), 216–222.CrossRefPubMed

Kessler, R. C., Sonnega, A., Bromet, E., Hughes, M., & Nelson, C. B. (1995). Posttraumatic stress disorder in the National Comorbidity Survey. Archives of general psychiatry, 52(12), 1048–1060.CrossRefPubMed

Brown, P. J., Recupero, P. R., & Stout, R. (1995). PTSD substance abuse comorbidity and treatment utilization. Addictive behaviors, 20(2), 251–254.CrossRefPubMed

Brown, P. J., Stout, R. L., & Mueller, T. (1999). Substance use disorder and posttraumatic stress disorder comorbidity: Addiction and psychiatric treatment rates. Psychology of Addictive Behaviors, 13(2), 115.CrossRef

Seal, K. H., Bertenthal, D., Miner, C. R., Sen, S., & Marmar, C. (2007). Bringing the war back home: Mental health disorders among 103 788 US veterans returning from Iraq and Afghanistan seen at Department of Veterans Affairs Facilities. Archives of Internal Medicine, 167(5), 476–482.CrossRefPubMed

Association, A. P. (2013). Diagnostic and Statistical Manual of Mental Disorders (DSM-5®): American Psychiatric Pub.CrossRef

DSM-5. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®): American Psychiatric Pub.

Tanielian, T. L., & Jaycox, L. (2008). Invisible wounds of war: Psychological and cognitive injuries, their consequences, and services to assist recovery (Vol. 1): Rand Corporation.

Hermes, E. D., Rosenheck, R. A., Desai, R., & Fontana, A. F. (2012a). Recent trends in the treatment of posttraumatic stress disorder and other mental disorders in the VHA. Psychiatric Services.

10.

Marmar, C. R., Schlenger, W., Henn-Haase, C., Qian, M., Purchia, E., Li, M.,. .. Horesh, D. (2015). Course of posttraumatic stress disorder 40 years after the Vietnam War: Findings from the National Vietnam Veterans Longitudinal Study. JAMA Psychiatry, 72(9), 875–881.

11.

Forneris, C. A. (2002). Outpatient care use among female veterans: Differences between mental health and non-mental health users. Military medicine, 167(1), 10.PubMed

12.

Berg, A., Breslau, N., Goodman, S., Lezak, M., Matchar, D., Mellman, T.,. .. Vega, W. (2008). Treatment of posttraumatic stress disorder: an assessment of the evidence. Institute of.

13.

Creamer, M., & Forbes, D. (2004). Treatment of posttraumatic stress disorder in military and veteran populations. Psychotherapy: Theory, Research, Practice, Training, 41(4), 388.

14.

Blake, D., Weathers, F., Nagy, L., Kaloupek, D., Klauminzer, G., Charney, D., & Keane, T. (1990). A clinician rating scale for assessing current and lifetime PTSD: The CAPS-1.

15.

Blake, D. D., Weathers, F. W., Nagy, L. M., Kaloupek, D. G., Gusman, F. D., Charney, D. S., & Keane, T. M. (1995). The development of a clinician-administered PTSD scale. Journal of traumatic stress, 8(1), 75–90.CrossRefPubMed

16.

Weathers, F. W., Keane, T. M., & Davidson, J. R. (2001). Clinician-Administered PTSD Scale: A review of the first ten years of research. Depression and anxiety, 13(3), 132–156.CrossRefPubMed

17.

Hermes, E. D., Sokoloff, D., Stroup, T. S., & Rosenheck, R. A. (2012b). Minimum clinically important difference in the Positive and Negative Syndrome Scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE). The Journal of clinical psychiatry, 73(4), 1,478–532.CrossRef

18.

Leucht, S., Kane, J. M., Kissling, W., Hamann, J., Etschel, E., & Engel, R. R. (2005b). What does the PANSS mean? Schizophrenia research, 79(2), 231–238.CrossRefPubMed

19.

Church, D., Geronilla, L., & Dinter, I. (2009). Psychological symptom change in veterans after six sessions of Emotional Freedom Techniques (EFT): An observational study. Electronic journal article]. International Journal of Healing and Caring, 9(1).

20.

Pigeon, W. R., Campbell, C. E., Possemato, K., & Ouimette, P. (2013). Longitudinal relationships of insomnia, nightmares, and PTSD severity in recent combat veterans. Journal of psychosomatic research, 75(6), 546–550.CrossRefPubMed

21.

Difede, J., Malta, L. S., Best, S., Henn-Haase, C., Metzler, T., Bryant, R., & Marmar, C. (2007). A randomized controlled clinical treatment trial for World Trade Center attack-related PTSD in disaster workers. The Journal of nervous and mental disease, 195(10), 861–865.CrossRefPubMed

22.

Hien, D. A., Jiang, H., Campbell, A. N., Hu, M.-C., Miele, G. M., Cohen, L. R.,. .. Robinson, J. (2010). Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network. American journal of Psychiatry.

23.

Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W., & Schuler, T. C. (2007). Understanding the minimum clinically important difference: a review of concepts and methods. The Spine Journal, 7(5), 541–546.CrossRefPubMed

24.

Hays, R. D., & Woolley, J. M. (2000). The concept of clinically meaningful difference in health-related quality-of-life research. Pharmacoeconomics, 18(5), 419–423.CrossRefPubMed

25.

Guyatt, G., Walter, S., & Norman, G. (1987). Measuring change over time: assessing the usefulness of evaluative instruments. Journal of chronic diseases, 40(2), 171–178.CrossRefPubMed

26.

Jaeschke, R., Singer, J., & Guyatt, G. H. (1989). Measurement of health status: ascertaining the minimal clinically important difference. Controlled clinical trials, 10(4), 407–415.CrossRefPubMed

27.

Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of clinical epidemiology, 61(2), 102–109.CrossRefPubMed

28.

Wells, G., Beaton, D., Shea, B., Boers, M., Simon, L., Strand, V.,. .. Tugwell, P. (2001). Minimal clinically important differences: review of methods. The Journal of rheumatology, 28(2), 406–412.

29.

Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of clinical epidemiology, 56(5), 395–407.CrossRefPubMed

30.

Lydick, E., & Epstein, R. (1993). Interpretation of quality of life changes. Quality of life research, 2(3), 221–226.CrossRefPubMed

31.

Leddy-Stacy, M. A., & Rosenheck, R. (2016). Obtaining employment as an anchor for estimating the minimum clinically important difference on the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatry research, 238, 304–309.CrossRefPubMed

32.

de Vet, H. C., Ostelo, R. W., Terwee, C. B., van der Roer, N., Knol, D. L., Beckerman, H.,. .. Bouter, L. M. (2007). Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approach. Quality of life research, 16(1), 131–142.

33.

Cohen, J. (1977). Statistical power analysis for the behavioral sciences (rev: Lawrence Erlbaum Associates, Inc.

34.

Deyo, R. A., Diehr, P., & Patrick, D. L. (1991). Reproducibility and responsiveness of health status measures statistics and strategies for evaluation. Controlled clinical trials, 12(4), S142-S158.CrossRef

35.

Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989). Effect sizes for interpreting changes in health status. Medical Care, 27(3), S178-S189.CrossRefPubMed

36.

Sloan, J., Vargas-Chanes, D., Kamath, C., Sargent, D., Novotny, P., Atherton, P.,. .. Loprinzi, C. (2003). Detecting worms, ducks and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures. J Cancer Integr Med, 1(1), 41–47.

37.

Walters, S. J., & Brazier, J. E. (2005). Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Quality of life research, 14(6), 1523–1532.CrossRefPubMed

38.

Krystal, J. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J. C., Jones, K. M., Vertrees, J. E.,. .. Group, V. A. C. S. N. (2011). Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service–related PTSD: a randomized trial. Jama, 306(5), 493–502.

39.

Hovens, J., Van der Ploeg, H., Klaarenbeek, M., Bramsen, I., Schreuder, J., & Rivero, V. V. (1994). The assessment of posttraumatic stress disorder: with the Clinician Administered PTSD Scale: Dutch results. Journal of clinical psychology, 50(3), 325–340.CrossRefPubMed

40.

Paunović, N., & Öst, L. G. (2005). Psychometric properties of a Swedish translation of the Clinician-Administered PTSD Scale-Diagnostic Version. Journal of traumatic stress, 18(2), 161–164.CrossRefPubMed

41.

Schnyder, U., & Moergeli, H. (2002). German version of clinician-administered PTSD scale. Journal of traumatic stress, 15(6), 487–492.CrossRefPubMed

42.

Lillywhite, A., & Neal, L. (1993). The importance of severity as a factor in post-traumatic stress disorder.

43.

Gearon, J. S., Bellack, A. S., & Tenhula, W. N. (2004). Preliminary reliability and validity of the Clinician-Administered PTSD Scale for schizophrenia. Journal of consulting and clinical psychology, 72(1), 121.CrossRefPubMed

44.

Lee, B. Y., Kim, Y., Yi, S. M., Eun, H. J., Kim, D. I., & Kim, J. Y. (1999). A reliability and validity study of a clinician-administered PTSD scale. Journal of Korean Neuropsychiatric Association, 38(3), 514–522.

45.

Newman, E., Kaloupek, D. G., & Keane, T. M. (1996). Assessment of posttraumatic stress disorder in clinical and research settings.

46.

Weathers, F., Litz, B., Huska, J., & Keane, T. (1994b). PTSD Checklist—Military Version (PCL-M) for DSM-IV. Boston: National Center for PTSD—Behavioral Science Division.

47.

Weathers, F., Litz, B., Herman, D., Huska, J., & Keane, T. (1994a). The PTSD checklist-civilian version (PCL-C). Boston, MA: National Center for PTSD.

48.

Weathers, F. W., Litz, B. T., Herman, D. S., Huska, J. A., & Keane, T. M. (1993). The PTSD Checklist (PCL): Reliability, validity, and diagnostic utility. Paper presented at the Annual Convention of the International Society for Traumatic Stress Studies.

49.

Association, A. P. (1987). Diagnostic and Statistical Manual of Mental Disorders-Revision: American Psychiatric Association.

50.

Creamer, M., Bell, R., & Failla, S. (2003). Psychometric properties of the impact of event scale—revised. Behaviour research and therapy, 41(12), 1489–1496.CrossRefPubMed

51.

Forbes, D., Creamer, M., & Biddle, D. (2001). The validity of the PTSD checklist as a measure of symptomatic change in combat-related PTSD. Behaviour research and therapy, 39(8), 977–986.CrossRefPubMed

52.

Dobie, D. J., Kivlahan, D. R., Maynard, C., Bush, K. R., McFall, M., Epler, A. J., & Bradley, K. A. (2002). Screening for post-traumatic stress disorder in female Veteran’s Affairs patients: validation of the PTSD checklist. General Hospital Psychiatry, 24(6), 367–374.CrossRefPubMed

53.

Lang, A. J., Laffaye, C., Satz, L. E., Dresselhaus, T. R., & Stein, M. B. (2003). Sensitivity and specificity of the PTSD checklist in detecting PTSD in female veterans in primary care. Journal of traumatic stress, 16(3), 257–264.CrossRefPubMed

54.

Walker, E. A., Newman, E., Dobie, D. J., Ciechanowski, P., & Katon, W. (2002). Validation of the PTSD checklist in an HMO sample of women. General Hospital Psychiatry, 24(6), 375–380.CrossRefPubMed

55.

Guy, W. (1976). Clinical global impression scale. The ECDEU Assessment Manual for Psychopharmacology-Revised Volume DHEW Publ No ADM, 76(338), 218–222.

56.

Hale, A., Corral, R.-M., Mencacci, C., Ruiz, J. S., Severo, C. A., & Gentil, V. (2010). Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study. International clinical psychopharmacology, 25(6), 305–314.CrossRefPubMed

57.

Hsieh, M.-H., Lin, W.-W., Chen, S.-T., Chen, K.-C., Chen, K.-P., Chiu, N.-Y.,. .. Lai, T.-J. (2010). A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting. Annals of General Psychiatry, 9(1), 1.

58.

Bandelow, B., Baldwin, D. S., Dolberg, O. T., Andersen, H. F., & Stein, D. J. (2006). What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder? The Journal of clinical psychiatry, 67(9), 1428–1434.CrossRefPubMed

59.

Leucht, S., & Engel, R. R. (2006). The relative sensitivity of the Clinical Global Impressions Scale and the Brief Psychiatric Rating Scale in antipsychotic drug trials. Neuropsychopharmacology, 31(2), 406–412.CrossRefPubMed

60.

Leucht, S., Kane, J. M., Kissling, W., Hamann, J., Etschel, E., & Engel, R. (2005a). Clinical implications of brief psychiatric rating scale scores. The British Journal of Psychiatry, 187(4), 366–371.CrossRefPubMed

61.

Spielmans, G. I., & McFall, J. P. (2006). A comparative meta-analysis of clinical global impressions change in antidepressant trials. The Journal of nervous and mental disease, 194(11), 845–852.CrossRefPubMed

62.

Zaider, T. I., Heimberg, R. G., Fresco, D., Schneier, F., & Liebowitz, M. (2003). Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychological medicine, 33(04), 611–622.CrossRefPubMed

63.

Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory-II. San Antonio, TX, 78204–72498.

64.

Hamilton, M. (1967). Development of a rating scale for primary depressive illness. British journal of social and clinical psychology, 6(4), 278–296.CrossRefPubMed

65.

Kørner, A., Lauritzen, L., Abelskov, K., Gulmann, N. C., Brodersen, A.-M., Wedervang-Jensen, T., & Kjeldgaard, K. M. (2007). Rating scales for depression in the elderly: external and internal validity. The Journal of clinical psychiatry, 68(3), 384–389.CrossRefPubMed

66.

Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. The British Journal of Psychiatry, 134(4), 382–389.CrossRefPubMed

67.

Riedel, M., Möller, H.-J., Obermeier, M., Schennach-Wolff, R., Bauer, M., Adli, M.,. .. Laux, G. (2010). Response and remission criteria in major depression–a validation of current practice. Journal of psychiatric research, 44(15), 1063–1068.

68.

Samsa, G., Edelman, D., Rothman, M. L., Williams, G. R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures. Pharmacoeconomics, 15(2), 141–155.CrossRefPubMed

69.

Spearman, C. (1904). The proof and measurement of association between two things. The American journal of psychology, 15(1), 72–101.CrossRef

70.

SAS Institute, I. (2011). SAS® 9.3: Software. SAS Institute, Inc. Cary, NC.

71.

Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. 2nd edn. Hillsdale, New Jersey: L: Erlbaum.

72.

Steenkamp, M. M., Litz, B. T., Hoge, C. W., & Marmar, C. R. (2015). Psychotherapy for military-related PTSD: A review of randomized clinical trials. Jama, 314(5), 489–500.CrossRefPubMed

73.

Davidson, J. R., Rothbaum, B. O., van der Kolk, B. A., Sikes, C. R., & Farfel, G. M. (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of general psychiatry, 58(5), 485–492.CrossRefPubMed

74.

Marshall, R. D., Beebe, K. L., Oldham, M., & Zaninelli, R. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. American journal of Psychiatry, 158(12), 1982–1988.CrossRefPubMed

75.

Schnurr, P. P., Friedman, M. J., Foy, D. W., Shea, M. T., Hsieh, F. Y., Lavori, P. W.,. .. Bernardy, N. C. (2003). Randomized trial of trauma-focused group therapy for posttraumatic stress disorder: Results from a Department of Veterans Affairs cooperative study. Archives of general psychiatry, 60(5), 481–489.

76.

Schnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Chow, B. K.,. .. Haug, R. (2007). Cognitive behavioral therapy for posttraumatic stress disorder in women: a randomized controlled trial. Jama, 297(8), 820–830.

77.

Sloan, J. A., Cella, D., & Hays, R. D. (2005). Clinical significance of patient-reported questionnaire data: another step toward consensus. Journal of clinical epidemiology, 58(12), 1217–1219.CrossRefPubMed

78.

Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T.,. .. Ader, D. N. (2008). Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. The Journal of Pain, 9(2), 105–121.

79.

Wisco, B. E., Marx, B. P., Miller, M. W., Wolf, E. J., Mota, N. P., Krystal, J. H.,. .. Pietrzak, R. H. (2016). Probable posttraumatic stress disorder in the US veteran population according to DSM-5: results from the National Health and Resilience in Veterans Study. The Journal of clinical psychiatry, 77(11), 1503–1510.

80.

Zoellner, L. A., Pruitt, L. D., Farach, F. J., & Jun, J. J. (2014). Understanding heterogeneity in PTSD: fear, dysphoria, and distress. Depression and anxiety, 31(2), 97–106.CrossRefPubMed

81.

Haagsma, J. A., Polinder, S., Olff, M., Toet, H., Bonsel, G. J., & van Beeck, E. F. (2012). Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency department. BMC psychiatry, 12(1), 1.CrossRefPubMedPubMedCentral

Titel: Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder
verfasst von: Elina A. Stefanovics
Robert A. Rosenheck
Karen M. Jones
Grant Huang
John H. Krystal
Publikationsdatum: 21.06.2017
Verlag: Springer US
Erschienen in: Psychiatric Quarterly / Ausgabe 1/2018
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI: https://doi.org/10.1007/s11126-017-9522-y

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Minimal Clinically Important Differences (MCID) in Assessing Outcomes of Post-Traumatic Stress Disorder

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool

Factor Structure of Teacher Ratings of the ODD Symptoms in Children

Establishing an Integrated Health Care Clinic in a Community Mental Health Center: Lessons Learned

Treatment for Depression and Health-Related Quality of Life among Adults with Arthritis

The Impact of ‘Being There’: Psychiatric Staff Attitudes on the Use of Restraint

Factors Associated with Length of Stay in Psychiatric Inpatient Services in London, UK

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie